Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours

Update Il y a 4 ans
Reference: NCT01795768

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the activity of the FGFR inhibitor AZD4547 in patients with FGFR1 or FGFR2 amplified breast, squamous lung and stomach cancer whose cancers have progressed following previous chemotherapy


Inclusion criteria

  • Gastric Cancer,Oesophageal Cancer,Breast Cancer,Squamous cell carcinoma of the lung

Links